MacroGenics, Inc. (MGNX)
2.04
-0.13
(-5.99%)
USD |
NASDAQ |
Nov 17, 16:00
2.04
0.00 (0.00%)
After-Hours: 20:00
MacroGenics Price : 2.04 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2.22 | 2.25 | 1.930 | 2.17 | 886958.0 |
| Nov 13, 2026 | 2.26 | 2.27 | 2.05 | 2.20 | 997842.0 |
| Nov 12, 2026 | 2.31 | 2.43 | 2.24 | 2.29 | 894630.0 |
| Nov 11, 2026 | 2.42 | 2.42 | 2.32 | 2.32 | 451231.0 |
| Nov 10, 2026 | 2.31 | 2.43 | 2.31 | 2.42 | 468035.0 |
| Nov 09, 2026 | 2.36 | 2.49 | 2.33 | 2.34 | 953369.0 |
| Nov 06, 2026 | 2.26 | 2.445 | 2.25 | 2.33 | 695812.0 |
| Nov 05, 2026 | 2.30 | 2.334 | 2.205 | 2.22 | 1.299M |
| Nov 04, 2026 | 2.39 | 2.46 | 2.23 | 2.31 | 919162.0 |
| Nov 03, 2026 | 2.36 | 2.49 | 2.260 | 2.33 | 409139.0 |
| Nov 02, 2026 | 2.41 | 2.535 | 2.32 | 2.33 | 766122.0 |
| Oct 30, 2026 | 2.37 | 2.435 | 2.235 | 2.40 | 1.183M |
| Oct 29, 2026 | 2.49 | 2.59 | 2.37 | 2.38 | 744480.0 |
| Oct 28, 2026 | 2.39 | 2.545 | 2.35 | 2.47 | 1.414M |
| Oct 27, 2026 | 2.20 | 2.560 | 2.158 | 2.44 | 2.120M |
| Oct 26, 2026 | 2.09 | 2.23 | 1.93 | 2.19 | 2.607M |
| Oct 23, 2026 | 3.55 | 3.565 | 2.13 | 2.25 | 4.010M |
| Oct 22, 2026 | 3.59 | 3.67 | 3.52 | 3.63 | 465521.0 |
| Oct 21, 2026 | 3.45 | 3.665 | 3.45 | 3.59 | 398266.0 |
| Oct 20, 2026 | 3.35 | 3.60 | 3.33 | 3.49 | 325410.0 |
| Oct 19, 2026 | 3.27 | 3.435 | 3.26 | 3.33 | 567618.0 |
| Oct 16, 2026 | 3.37 | 3.45 | 3.235 | 3.25 | 410557.0 |
| Oct 15, 2026 | 3.34 | 3.435 | 3.30 | 3.37 | 578086.0 |
| Oct 14, 2026 | 3.42 | 3.42 | 3.19 | 3.31 | 906754.0 |
| Oct 13, 2026 | 3.73 | 3.73 | 3.38 | 3.42 | 559141.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.30 |
| Alnylam Pharmaceuticals, Inc. | 156.54 |
| Anika Therapeutics, Inc. | 12.89 |
| Savara, Inc. | 4.475 |
| Arrowhead Pharmaceuticals, Inc. | 42.96 |
Price Related Metrics
| PS Ratio | 1.142 |
| Price to Book Value | 5.181 |
| Earnings Yield | -40.84% |
| Market Cap | 130.31M |